Leucine, a branched-chain amino acid, functions as a potent activator of mTOR signaling independent of insulin, making it particularly valuable in insulin-resistant states common in sarcopenia and cachexia (Beaudry et al., 2022). The gene discussed is MTOR; the disease is sarcopenia.